Klotho Neurosciences, Inc. announced on February 17, 2026, that its stockholders approved a reverse stock split and increased the number of shares available in its 2024 Equity Incentive Plan to 10 million. The reverse stock split will be executed at a ratio between 1-for-2 and 1-for-50, based on the Board's decision.